Dr. Reddy's Files FDA Drugmaster Application For Nexium
Dr Reddy's has filed a "drugmaster" document with the FDA, usually the precursor to a full-blown patent challenge. The submission of a drugmaster file with the FDA typically precedes an abbreviated new drug application (ANDA).
Dr. Reddy’s formal application could be prepared within six months to file for regulatory approval for its version...
To view the full article, register now.